| 31309543 |
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies
Griffin, JD,
Yang, J,
Buhrlage, SJ,
Letard, S,
Stone, RM,
Tiv, HL,
Meng, C,
Case, AE,
Gokhale, PC,
Liu, X,
Gray, N,
Sattler, M,
Dubreuil, P,
Weisberg, E,
Wang, J,
Adamia, S
|
Br. J. Haematol. |
2019 |
| 29093181 |
A precision therapy against cancers driven by KIT/PDGFRA mutations
Heinrich, MC,
Zhang, Y,
Hodous, BL,
Shutes, A,
Lengauer, C,
Evans, EK,
Kohl, N,
Wolf, B,
Schöffski, P,
Zhu, XJ,
Kim, JL,
Gebreyohannes, YK,
Gardino, AK,
Wozniak, A,
DiPietro, L,
Lydon, N,
Wilson, K,
Brooijmans, N,
Schmidt-Kittler, O,
Boral, A,
Miller, S,
LaBranche, TP,
Deangelo, DJ,
Davis, A,
Guzi, T,
Wilson, D
|
Sci Transl Med |
2017 |
